Virgen de la Arrixaca University Clinical Hospital
If you are the contact person for this centre and you wish to make any changes, please contact us.
Head of the Cardiology Department at the Virgen de la Arrixaca Hospital and Professor at the University of Murcia
A review conducted by the Cochrane Collaboration analyzed the effects of colchicine—a medication commonly used to treat some rheumatic diseases—on people who had already experienced a cardiovascular event. The review included 12 clinical trials with more than 23,000 patients and concluded that colchicine reduces the risk of stroke or heart attack in these individuals. Overall, for every 1,000 people treated, there were 9 fewer heart attacks and 8 fewer strokes compared to those who did not take the medication, with no apparent serious side effects.